• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在注射毒品者中,阿片类药物过量反应培训的流行和差异:旧金山的纳洛酮培训。

Prevalence and disparities in opioid overdose response training among people who inject drugs, San Francisco: Naloxone training among injectors in San Francisco.

机构信息

University of California, Berkeley.

San Francisco Department of Public Health.

出版信息

Int J Drug Policy. 2021 Apr;90:102778. doi: 10.1016/j.drugpo.2020.102778. Epub 2020 Jun 4.

DOI:10.1016/j.drugpo.2020.102778
PMID:32507683
Abstract

BACKGROUND

Expanding naloxone training stands to reduce opioid-related overdose deaths. The current study assessed the prevalence of overdose response training and use of naloxone among people who inject drugs (PWID).

METHODS

Data were from a survey of PWID in San Francisco in 2018, recruited by respondent-driven sampling (RDS). Eligibility criteria were age over 18 years, injected non-prescribed drugs in the last year, San Francisco residence, and referral by another participant. Interviews collected demographic characteristics and injection-related behavior.

RESULTS

The sample (N=458) was majority male (67.5%) and over 45.5 years. Over three-fourths (76.0%) injected primarily opioids. Overall, 62.9% received overdose response training and 68.8% owned a naloxone kit. A majority (77.9%) had witnessed an overdose in the past year, of whom 55.8% used naloxone the last time they witnessed an overdose. Receiving overdose response training was significantly lower among persons of non-white race/ethnicity compared to whites (adjusted odds ratio [AOR] 0.43, 95% CI 0.27, 0.69) and higher among those who owned naloxone (AOR 6.29, 95% confidence interval [CI] 3.95, 10.02) and used syringe exchange programs (AOR 3.51, 95% CI 1.41, 8.79).

CONCLUSION

While the majority of PWID have had overdose response training, gaps and disparities persist in promotion of naloxone use.

摘要

背景

扩大纳洛酮培训有助于降低阿片类药物相关的过量死亡。本研究评估了注射吸毒者(PWID)中过量反应培训和纳洛酮使用的流行率。

方法

数据来自 2018 年旧金山对 PWID 的一项调查,通过应答者驱动抽样(RDS)招募。入选标准为年龄大于 18 岁,过去一年中注射过非处方药物,在旧金山居住,并由另一名参与者推荐。访谈收集人口统计学特征和注射相关行为。

结果

样本(N=458)主要为男性(67.5%),年龄超过 45.5 岁。超过四分之三(76.0%)的人主要注射阿片类药物。总体而言,62.9%的人接受过过量反应培训,68.8%的人拥有纳洛酮套件。大多数(77.9%)人在过去一年中目睹过一次过量,其中 55.8%的人在最后一次目睹过量时使用了纳洛酮。与白人相比,非白人和少数族裔(调整后的优势比 [AOR] 0.43,95%置信区间 [CI] 0.27,0.69)接受过量反应培训的比例显著较低,而拥有纳洛酮(AOR 6.29,95%CI 3.95,10.02)和使用注射器交换计划(AOR 3.51,95%CI 1.41,8.79)的人接受培训的比例较高。

结论

尽管大多数 PWID 都接受了过量反应培训,但在推广纳洛酮使用方面仍存在差距和差异。

相似文献

1
Prevalence and disparities in opioid overdose response training among people who inject drugs, San Francisco: Naloxone training among injectors in San Francisco.在注射毒品者中,阿片类药物过量反应培训的流行和差异:旧金山的纳洛酮培训。
Int J Drug Policy. 2021 Apr;90:102778. doi: 10.1016/j.drugpo.2020.102778. Epub 2020 Jun 4.
2
Fentanyl self-testing in a community-based sample of people who inject drugs, San Francisco.社区注射吸毒人群中芬太尼自我检测,旧金山。
Int J Drug Policy. 2020 Aug;82:102787. doi: 10.1016/j.drugpo.2020.102787. Epub 2020 Jun 6.
3
The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA.纳洛酮传递链:在加利福尼亚州洛杉矶和旧金山的注射吸毒者中,确定纳洛酮获取方面的差异。
Drug Alcohol Depend. 2021 Aug 1;225:108759. doi: 10.1016/j.drugalcdep.2021.108759. Epub 2021 May 21.
4
Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.在纽约市阿片类药物过量流行的芬太尼浪潮期间,注射吸毒者之间纳洛酮拥有情况存在差距,2018 年。
Subst Abus. 2022;43(1):1172-1179. doi: 10.1080/08897077.2022.2074597.
5
Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs.社区中使用阿片类药物注射的人群中携带纳洛酮的流行率及其相关因素。
Int J Drug Policy. 2019 Nov;73:32-35. doi: 10.1016/j.drugpo.2019.07.010. Epub 2019 Jul 20.
6
Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland.致命性药物过量预防和纳洛酮使用经验:马里兰州巴尔的摩市一个基于社区的注射吸毒者队列的横断面研究。
PLoS One. 2020 Mar 11;15(3):e0230127. doi: 10.1371/journal.pone.0230127. eCollection 2020.
7
Perception and Correlates of Opioid Overdose Risk Among Overdose Survivors Who Use Nonprescribed Opioids in San Francisco and Boston.旧金山和波士顿非处方阿片类药物使用者的过量幸存者对阿片类药物过量风险的认知及相关因素。
Subst Use Addctn J. 2024 Oct;45(4):559-567. doi: 10.1177/29767342241237202. Epub 2024 Mar 8.
8
High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.马来西亚注射毒品者中非致命性药物过量的高流行率:一项横断面研究中药物过量的相关因素及对药物过量预防的启示
Int J Drug Policy. 2015 Jul;26(7):675-81. doi: 10.1016/j.drugpo.2014.11.010. Epub 2014 Dec 2.
9
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.在澳大利亚,近期使用过阿片类药物或接受过阿片类激动剂治疗的人群中,非致命性阿片类药物过量、纳洛酮获取和纳洛酮培训:ETHOS Engage 研究。
Int J Drug Policy. 2021 Oct;96:103421. doi: 10.1016/j.drugpo.2021.103421. Epub 2021 Aug 25.
10
Intravenous fentanyl use among people who inject drugs in Australia.澳大利亚注射吸毒人群中静脉注射芬太尼的使用情况。
Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S314-S322. doi: 10.1111/dar.12668. Epub 2018 Feb 6.

引用本文的文献

1
Bystander Presence and Naloxone Administration During Fatal Opioid-involved Overdoses in Rhode Island: Implications for Naloxone Coverage Among Families and Peers.罗德岛致命阿片类药物过量使用期间旁观者的在场情况及纳洛酮的使用:对家庭和同伴中纳洛酮覆盖范围的影响
J Addict Med. 2025 Apr 25. doi: 10.1097/ADM.0000000000001502.
2
A Social History of Opioids' Crimedical Cycle.阿片类药物犯罪循环的社会史。
Addict Res Theory. 2024;32(6):446-454. doi: 10.1080/16066359.2023.2282528. Epub 2023 Dec 2.
3
A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugs.
一项混合方法研究,旨在为加利福尼亚州圣地亚哥的致命过量预防提供信息:来自吸毒者的观点。
Int J Drug Policy. 2024 Nov;133:104577. doi: 10.1016/j.drugpo.2024.104577. Epub 2024 Sep 14.
4
Racialized environments and syringe services program implementation: County-level factors.种族化环境与注射器具提供计划实施:县级因素。
Drug Alcohol Depend. 2024 Oct 1;263:112430. doi: 10.1016/j.drugalcdep.2024.112430. Epub 2024 Aug 28.
5
Bystander preference for naloxone products: a field experiment.旁观者对纳洛酮产品的偏好:一项现场实验。
Harm Reduct J. 2023 Nov 28;20(1):171. doi: 10.1186/s12954-023-00904-9.
6
Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City.种族/民族差异与阿片类药物过量预防:纽约市使用阿片类药物的白种人、拉丁裔和非裔人群中纳洛酮护理级联的比较。
Harm Reduct J. 2023 Feb 25;20(1):24. doi: 10.1186/s12954-023-00736-7.
7
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment.减少伤害行为与美沙酮治疗患者携带纳洛酮有关。
Harm Reduct J. 2023 Feb 14;20(1):17. doi: 10.1186/s12954-023-00745-6.
8
Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019.2019 年,在 38 个美国司法管辖区的州非故意药物过量报告系统中,阿片类药物过量死亡患者接受了纳洛酮治疗。
Drug Alcohol Depend. 2022 Jun 1;235:109467. doi: 10.1016/j.drugalcdep.2022.109467. Epub 2022 Apr 16.